4
Changes in Ownership
Protagenic Therapeutics, Inc.new Filed Acc 0001493152-21-010335
Chief Financial Officer bought 2,000 shares at $2.29 ($4,580)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X03/ownership.xml…